PhD Program in Biotechnology Research and Development, School of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Clin Transl Sci. 2020 Nov;13(6):1045-1047. doi: 10.1111/cts.12813. Epub 2020 Jun 7.
Although cell-based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual-track regulatory framework for cell-based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell-based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell-based therapy.
虽然细胞治疗已成为一种有前途的治疗方法,但其实践和评估过程仍未标准化。因此,日本为细胞治疗制定了双轨监管框架,旨在促进和规范这些疗法,以确保患者能够获得安全有效的治疗。受这种途径的影响,台湾于 2018 年采用了该框架并启动了自己的细胞治疗监管。本文探讨了日本在制定细胞治疗法规方面是如何影响台湾的。